By Regulatory Approvals — FDA Approves MSI Companion Diagnostic for Pembrolizumab in MSI-H Tumors Oncology Nursing News
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 12, 2026.